NCT02912559 2026-02-02
Combination Chemotherapy With or Without Atezolizumab in Treating Patients With Stage III Colon Cancer and Deficient DNA Mismatch Repair
National Cancer Institute (NCI)
Phase 3 Active not recruiting
Clinical Trials
1 trialsPhase 3 × Colorectal Neoplasms, Hereditary Nonpolyposis × Magnetic Resonance Spectroscopy × Clear all